Related Experiment Video
Updated: Mar 22, 2026

Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification
Published on: December 3, 2016
Children with severe Osteogenesis imperfecta and short stature present on average with normal IGF-I and IGFBP-3
Insights
Children with Osteogenesis Imperfecta (OI) show Insulin-like Growth Factor-I (IGF-I) and IGF Binding Protein-3 (IGFBP-3) levels in the lower normal range. These growth factor levels do not significantly differ between OI types.
Area of Science:
- Pediatric Endocrinology
- Skeletal Dysplasias
- Growth Factor Research
Background:
- Osteogenesis Imperfecta (OI) is a genetic disorder causing bone fragility and growth impairment.
- Limited data exists on Insulin-like Growth Factor-I (IGF-I) and IGF Binding Protein-3 (IGFBP-3) levels in children with OI.
- Understanding these growth factors is crucial for managing OI-related growth disturbances.
Purpose of the Study:
- To investigate IGF-I and IGFBP-3 levels in children diagnosed with various types of Osteogenesis Imperfecta.
- To determine if OI severity, categorized by type, correlates with differences in IGF-I and IGFBP-3 levels.
Main Methods:
- Retrospective cross-sectional study involving 60 pediatric patients with OI.
- Assessed serum levels of IGF-I and IGFBP-3.
- Compared growth factor levels between different types of OI, specifically type 3 and type 4.
Main Results:
- Mean IGF-I levels were found in the lower normal range (137.4±109.1 μg/L).
- Mean IGFBP-3 levels were within the normal range (3.105±1.175 mg/L).
- No statistically significant differences in IGF-I or IGFBP-3 levels were observed between children with OI type 3 and type 4.
Conclusions:
- Children with Osteogenesis Imperfecta, regardless of severity, exhibit IGF-I and IGFBP-3 levels in the lower end of the normal spectrum.
- The specific type of OI does not appear to significantly impact IGF-I and IGFBP-3 levels in the studied pediatric cohort.
Background:
Osteogenesis imperfecta (OI) is characterized by bone fragility and short stature. Data about IGF-I/IGFBP-3 levels are rare in OI. Therefore IGF-I/IGFBP-3 levels in children with different types of OI were investigated.
Methods:
IGF-I and IGFBP-3 levels of 60 children (male n=38) were assessed in a retrospective cross-sectional setting.
Results:
Height/weight was significant different [height z-score type 3 versus type 4: p=0.0011 and weight (p≤0.0001)] between OI type 3 and 4. Mean IGF-I levels were in the lower normal range (mean±SD level 137.4±109.1 μg/L). Mean IGFBP-3 measurements were in the normal range (mean±SD 3.105±1.175 mg/L). No significant differences between OI type 3 and 4 children have been observed (IGF-I: p=0.0906; IGFBP-3: p=0.2042).
Conclusions:
Patients with different severities of OI have IGF-I and IGFBP-3 levels in the lower normal range. The type of OI does not significantly influence these growth factors.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Nature and Nurture
Changes in the Appendicular Skeleton with Age
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
Bone Formation by Endochondral Ossification
Bone Formation by Intramembranous Ossification
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...

